VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,486,853 | -31.4% | 6,361,723 | 0.0% | 3.88% | -20.7% |
| Q2 2023 | $19,657,724 | -42.6% | 6,361,723 | 0.0% | 4.90% | -44.1% |
| Q1 2023 | $34,226,070 | -19.1% | 6,361,723 | 0.0% | 8.75% | -23.0% |
| Q4 2022 | $42,305,458 | +67.1% | 6,361,723 | 0.0% | 11.37% | +134.4% |
| Q3 2022 | $25,320,000 | -19.9% | 6,361,723 | 0.0% | 4.85% | -38.0% |
| Q2 2022 | $31,618,000 | -17.7% | 6,361,723 | 0.0% | 7.82% | -6.8% |
| Q1 2022 | $38,425,000 | -48.0% | 6,361,723 | 0.0% | 8.39% | -39.5% |
| Q4 2021 | $73,923,000 | -29.6% | 6,361,723 | -4.9% | 13.88% | -34.9% |
| Q3 2021 | $104,937,000 | -15.9% | 6,692,429 | 0.0% | 21.31% | -32.2% |
| Q2 2021 | $124,814,000 | -56.7% | 6,692,429 | 0.0% | 31.41% | -39.5% |
| Q1 2021 | $288,444,000 | – | 6,692,429 | – | 51.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |